Covaxin

Delhi’s vaccine stock to last four days, says bulletin

11:36 pm July 29, 2021

New Delhi: The national capital’s stock of anti-coronavirus vaccine will last for four days, according to a COVID Vaccination Bulletin issued by the Delhi government on Thursday. As of Thursday morning, the balance stock of Covaxin and Covishield were 2,17,030 and 6,09,610 doses respectively. The bulletin noted that only 20 per cent of Covaxin stock […]

Read More
Rollout of Sputnik-V COVID vaccine in Prayagraj soon

Rollout of Sputnik-V COVID vaccine in Prayagraj soon

11:16 pm July 20, 2021

Aditya Vikram Singh/ Prayagraj: A private hospital in Prayagraj has announced to launch vaccination of Prayagraj denizens with the Russian Covid vaccine Sputnik-V, the third vaccine after India’s own two vaccines the Covaxin and the Covishield. The Russian vaccine Sputnik-V is expected to be launched very soon. But the people have to dole out vaccination […]

Read More

AP all set to carry out huge vaccination drive on Sunday

11:28 pm June 19, 2021

Amaravati: Andhra Pradesh is all set to carry out a huge vaccination drive on June 20, targeting about eight to ten lakh people a day. Though officially no target has been announced, the top health authorities told all 13 District Collectors that the objective is to vaccinate 8-10 lakh people in a day. “We have […]

Read More

BJP accuses Punjab govt of profiteering from vaccination

11:19 pm June 4, 2021

New Delhi: The BJP on Friday alleged that the Congress government in Punjab is profiteering from COVID-19 vaccination by selling vaccine doses procured under state quota to private hospitals at higher rates. Referring to media reports, Union minister Prakash Javadekar said the Punjab government got over 1.40 lakh doses of Covaxin at Rs 400 each. […]

Read More

Pursuing Pfizer, J&J and Moderna since mid-2020 for earliest possible vaccine imports: Govt

5:52 pm May 27, 2021

New Delhi: Facing accusations of delay in placing orders for vaccines, the government on Thursday defended its vaccine procurement policy saying it has been pursuing Pfizer, J&J and Moderna since mid-2020 for the earliest possible imports, and has even waived local trials for well-established foreign vaccine makers. ”Buying vaccines internationally is not similar to buying ‘off-the-shelf items,” the […]

Read More